Cargando…

Fetal haemopoiesis marking low-grade urinary bladder cancer

BACKGROUND: The immunohistochemical features of fetal haemoglobin cells and their distribution patterns in solid tumours, such as colorectal cancer and blastomas, suggest that fetal haemopoiesis may take place in these tumour tissues. These locally highly concentrated fetal haemoglobin (HbF) cells m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wolk, M, Martin, J E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405209/ https://www.ncbi.nlm.nih.gov/pubmed/22735903 http://dx.doi.org/10.1038/bjc.2012.268

Ejemplares similares

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer
por: Miah, S, et al.
Publicado: (2012)

Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
por: Bryan, R T, et al.
Publicado: (2014)

Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins
por: Khadjavi, A, et al.
Publicado: (2015)

Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM
por: Bryan, R T, et al.
Publicado: (2015)

SIFD as a novel cause of severe fetal hydrops and neonatal anaemia with iron loading and marked extramedullary haemopoiesis
por: Barton, Chris, et al.
Publicado: (2018)

Low ANXA10 expression is associated with disease aggressiveness in bladder cancer
por: Munksgaard, P P, et al.
Publicado: (2011)

Dipeptidase 1 (DPEP1) is a marker for the transition from low-grade to high-grade intraepithelial neoplasia and an adverse prognostic factor in colorectal cancer
por: Eisenach, P A, et al.
Publicado: (2013)

p53 immunodetection of liquid-based processed urinary samples helps to identify bladder tumours with a higher risk of progression
por: Piaton, E, et al.
Publicado: (2005)

Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade
por: Burger, M, et al.
Publicado: (2007)

A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance
por: Sapre, Nikhil, et al.
Publicado: (2016)

CELLULAR DYNAMICS OF HAEMOPOIESIS
Publicado: (1980)

Foetal haemoglobin-blood cells (F-cells) as a feature of embryonic tumours (blastomas)
por: Wolk, M, et al.
Publicado: (2007)

Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms
por: Nishikawa, G, et al.
Publicado: (2013)

Human papillomaviral load changes in low-grade squamous intraepithelial lesions of the uterine cervix
por: Ho, C-M, et al.
Publicado: (2006)

EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo
por: Wei, J-H, et al.
Publicado: (2014)

MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9
por: Jia, A Y, et al.
Publicado: (2014)

Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions
por: Brismar-Wendel, S, et al.
Publicado: (2009)

AIB1 predicts bladder cancer outcome and promotes bladder cancer cell proliferation through AKT and E2F1
por: Tong, Z-T, et al.
Publicado: (2013)

ASPM and microcephalin expression in epithelial ovarian cancer correlates with tumour grade and survival
por: Brüning-Richardson, A, et al.
Publicado: (2011)

UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer
por: Unoki, M, et al.
Publicado: (2009)

Expression of NRG1 and its receptors in human bladder cancer
por: Forster, J A, et al.
Publicado: (2011)

Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer
por: Andersen, J B, et al.
Publicado: (2006)

Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer
por: Ord, J J, et al.
Publicado: (2005)

Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours
por: Weidlich, S, et al.
Publicado: (2011)

Prognostic value of increase in transcript levels of Tp73 ΔEx2-3 isoforms in low-grade glioma patients
por: Wager, M, et al.
Publicado: (2006)

The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer
por: Villadsen, S B, et al.
Publicado: (2012)

High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT–PCR mRNA expression profile
por: Baldewijns, M M, et al.
Publicado: (2007)

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer
por: Boman, K, et al.
Publicado: (2013)

High expression of RelA/p65 is associated with activation of nuclear factor-κB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis
por: Weichert, W, et al.
Publicado: (2007)

Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status
por: Fritzsche, F, et al.
Publicado: (2006)

Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers
por: Shao, R, et al.
Publicado: (2011)

Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma
por: Shimwell, N J, et al.
Publicado: (2013)

(1)H-NMR urinary metabolomic profiling for diagnosis of gastric cancer
por: Chan, Angela W, et al.
Publicado: (2016)

Diagnosis of bladder cancer by immunocytochemical detection of minichromosome maintenance protein-2 in cells retrieved from urine
por: Saeb-Parsy, K, et al.
Publicado: (2012)

Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays
por: Aleman, A, et al.
Publicado: (2008)

Increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of bladder cancer
por: Pardini, Barbara, et al.
Publicado: (2017)

Molecular aspects of a negative regulator of haemopoiesis.
por: Plumb, M., et al.
Publicado: (1991)

Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry
por: Silva, C L, et al.
Publicado: (2011)

Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer
por: Irlam-Jones, J J, et al.
Publicado: (2016)

Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy
por: Bhindi, Bimal, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dvt15m3gq0ok0ukklkgog823oq